Sunshine Biopharma Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sunshine Biopharma Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Sunshine Biopharma Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 2M shares, a 92.2% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2M -23.7M -92.2% Nov 5, 2024 10-Q 2024-11-05
Q2 2024 18.9M -6.8M -26.4% May 17, 2024 10-Q 2024-05-20
Q1 2024 99.5M +76.9M +340% Mar 28, 2024 10-K 2024-03-28
Q3 2023 25.7M +3.09M +13.7% Nov 13, 2023 10-Q 2023-11-13
Q2 2023 25.7M +6.86M +36.3% Aug 10, 2023 10-Q 2023-08-10
Q1 2023 22.6M +15.5M +217% Mar 31, 2023 10-K 2023-04-04
Q3 2022 22.6M -493M -95.6% Nov 7, 2022 10-Q 2022-11-07
Q2 2022 18.9M -491M -96.3% Aug 3, 2022 10-Q 2022-08-03
Q1 2022 7.13M -458M -98.5% Mar 5, 2022 10-K 2022-03-21
Q4 2021 0 Nov 15, 2021 10-Q 2021-11-09
Q3 2021 515M +183M +55% Nov 9, 2021 10-Q 2021-11-09
Q2 2021 510M +397M +352% Aug 9, 2021 10-Q 2021-08-09
Q1 2021 465M +395M +565% Mar 30, 2021 10-K 2021-03-30
Q3 2020 332M -188M -36.1% Nov 10, 2020 10-Q 2020-11-12
Q2 2020 113M +17.5M +18.3% May 18, 2020 10-Q 2020-05-18
Q1 2020 69.9M -19.4M -21.7% Apr 30, 2020 10-K 2020-05-01
Q3 2019 520M Nov 13, 2019 10-Q 2019-11-13
Q2 2019 95.4M -873M -90.1% May 20, 2019 10-Q 2019-05-20
Q1 2019 89.3M -859M -90.6% Apr 11, 2019 10-K 2019-04-12
Q4 2018 1.63B +714M +77.7% Nov 15, 2018 10-Q 2018-11-16
Q2 2018 969M +50.9M +5.54% May 21, 2018 10-Q 2018-05-22
Q1 2018 948M +96.1M +11.3% Mar 28, 2018 10-K 2018-04-02
Q4 2017 919M Nov 15, 2017 10-Q 2017-11-15
Q2 2017 918M Aug 11, 2017 10-Q 2017-08-11
Q1 2017 852M +629M +282% Apr 12, 2017 10-K 2017-04-17
Q3 2016 686M +549M +399% Nov 14, 2016 10-Q 2016-11-14
Q1 2016 223M +146M +189% Mar 24, 2016 10-K 2016-03-25
Q3 2015 138M +68.6M +99.6% Nov 4, 2015 10-Q 2015-11-04
Q2 2015 129M +61M +89.4% Aug 6, 2015 10-Q 2015-08-06
Q1 2015 77.1M +11.8M +18% Mar 9, 2015 10-K 2015-03-11
Q3 2014 68.9M +6.74M +10.8% Nov 10, 2014 10-Q 2014-11-12
Q2 2014 68.3M +11.8M +21% Aug 12, 2014 10-Q 2014-08-12
Q1 2014 65.3M +13.5M +26.1% May 8, 2014 10-Q 2014-05-09
Q3 2013 62.2M +10.8M +21% Nov 4, 2013 10-K 2014-03-19
Q2 2013 56.4M +6.35M +12.7% Aug 5, 2013 10-Q 2013-08-06
Q1 2013 51.8M +3.04M +6.23% Mar 13, 2013 10-K 2013-03-15
Q3 2012 51.4M +20.4M +65.6% Nov 7, 2012 10-Q 2012-11-08
Q2 2012 50.1M +19.4M +63.1% Aug 3, 2012 10-Q 2012-08-08
Q1 2012 48.7M Mar 15, 2012 10-K 2012-03-19
Q3 2011 31M Nov 7, 2011 10-Q 2011-11-08
Q2 2011 30.7M Aug 9, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.